IGM Biosciences Inc Capital Reinvestment Ratio

Latest as of June 2022: 0.02x

IGM Biosciences Inc capital reinvestment ratio. IGM Biosciences Inc (IGMS) has a Capital Reinvestment Ratio of 0.02x as of June 2022, meaning it reinvests 0% of its operating cash flow ($111.29 Million) in capital expenditures ($1.82 Million). Check cash flow reinvestment rate of IGM Biosciences Inc to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$111.29 Million

USD

Capital Expenditures

$1.82 Million

USD

Data as of

Jun 2022

Most recent filing

IGM Biosciences Inc Capital Reinvestment Ratio by Year (None–None)

IGM Biosciences Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see how efficiently does IGM Biosciences Inc generate cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow